Intel Feed[]
/ trauma.rejection.unit: Truan Project
During the Agent Operations Program, initiated by EuroCorp in 2041, test subjects experienced stress-induced relapses and tissue breakdown, rendering over 80% of the accepted stock useless.
The former chief-scientists of Euroline Medical's Leon RD facility in Neu-Hessen, Prof. Gabriel Truan (68), was brought out of retirement and moved to EuroCorp's BlackTen research station in Milford-Syracuse. The confirmed budget for the project was 350 billion dollars.
The first prototype, dubbed "Leonardo", was used in clinical trials on Agents 2043 to 2044. It introduced customizable immune system protocols and desensitized natural reactions of the adrenal gland processor, which had previously proved hard to implement with high conversion efficiency.
In August 27, 2051, Prof. Truan was killed during a covert attack on the BlackTen station. The hostile operatives were apprehended, but no trace was discovered of their apparent allegiance. Five were unchipped and three carried heavily-modified blackmarket meldware.
The Milford-Syracuse BlackTen research station was officially closed down and three prototype devices, with limited operating capacity, were introduced into the Agent Operations Program.
/ end of entry